Activation of class I Phosphoinositide 3-kinases (PI3Ks) by mutation or overexpression closely correlates with the development of various human cancers. Class I PI3Ks are heterodimers composed of p110 catalytic subunits and regulatory subunits represented by p85. PAQR3 has been found to inhibit p110α activity by blocking its interaction with p85. In this study, we identified the N-terminal 6-55 amino acid residues of PAQR3 being sufficient for its interaction with p110α. A synthetic peptide, P6-55, that contains the N-terminus of PAQR3 could disrupt the interactions of p110α with both PAQR3 and p85.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2eEqh8f
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: June 2017 Source: Anesthesiology Clinics, Volume 35, Issue 2 Author(s): Anair Beverly, Alan D. Kaye, Olle Ljungqvist, R...
-
At the King’s Fund’s annual conference on leadership and management last week, NHS England’s chief executive, Simon Stevens, found an innova...
-
Abstract Kimchi was prepared with different types of salts: purified salt (PS), solar salt aged for 1 year (SS1), aged for 3 years (SS3), a...
-
Abstract Although Nobori ® , with a bioresorbable polymer and biolimus A9 abluminal coating, has unique characteristics, few data exist re...
-
http://ift.tt/2rdV14q
-
Abstract In this study we investigated whether exerting an impulse on a Chronic Total Occlusion (CTO) improves the success rate of CTO cro...
-
Zusammenfassung Nichtmelanozytärer Hautkrebs und seine Frühformen sind aufgrund von steigender Inzidenz und Prävalenz häufige Diagnosen im...
-
2016-10-05T05-46-18Z Source: International Journal of Research in Medical Sciences Noha Seada, Mostafa G. M. Mostafa. Background: Heart...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου